. rLj-112 changed the protein levels of caspase 3, cleaved caspase 3, cleaved caspase 7, and cleaved PARP in B16 cells. Western blots (original images) showed the level of caspase 3, cleaved caspase 3, cleaved caspase 7, and cleaved PARP in B16 cells treated with 0, 0.5, 1.5 and 2.5 M rLj-112. GAPDH was used as a loading control.
. rLj-112 changed the protein levels of caspase 3, cleaved caspase 3, cleaved caspase 7, and cleaved PARP in B16 cells. Western blots (original images) showed the level of caspase 3, cleaved caspase 3, cleaved caspase 7, and cleaved PARP in B16 cells treated with 0, 0.5, 1.5 and 2.5 M rLj-112. GAPDH was used as a loading control. Figure S2 . rLj-112 suppressed the activation of EGFR pathway in B16 cells. Western blots (original images) showed the levels of Akt, p-Akt, PI3K, p-PI3K, p-EGFR, p-p38 and p-ERK1/2 in B16 cells treated with 0, 0.5, 1.5 and 2.5 M rLj-112, respectively. GAPDH served as a loading control.
